Skip to main content
Clinical Trials/IRCT20141217020351N11
IRCT20141217020351N11
Completed
Phase 4

The effect of platelet-rich plasma injection in the ovary on the number of oocytes; Oocyte quality and antimullerian hormone in cases of poor ovarian Responses.

Tehran University of Medical Sciences0 sites44 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
44
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • The second cycle of embryo transfer
  • Criteria for detecting poor ovarian function based on the Bologna criterion
  • Age less than 45 years
  • History of having at least three oocytes in the previous cycle
  • AMH hormone less than 1\.1 ng / ml
  • BMI less than 30kg/m2
  • At least ten million sperm and three percent sperm with a normal morphology

Exclusion Criteria

  • Immunological diseases
  • Hematological diseases
  • Chromosomal or genetic disorder
  • Uterine disorders
  • Hemoglobin level less than 11 grams per deciliter
  • Platelets less than one hundred and fifty thousand per cubic millimeter
  • Systemic use of corticosteroids within two weeks before the procedure
  • Hypothyroidism
  • Respiratory tract infections
  • Kidney failure

Outcomes

Primary Outcomes

Not specified

Similar Trials